倾向匹配分析:溶栓患者一年居家时间与死亡率
研究基于加拿大安大略卒中登记,将2002至2013年接受r-tPA治疗的4449例缺血性卒中患者与未治疗患者进行倾向评分匹配,比较1年居家时间、养老院入住与全因死亡。结果显示溶栓组1年居家时间更多、养老院入住更少,两组1年全因死亡率相似。
要点
- 溶栓组1年平均居家248.9天,高于未治疗组239.4天。
- 溶栓组1年养老院入住率9.4%,低于未治疗组12.2%。
- 两组1年全因死亡率相似,13.2%对12.4%。
核心结论
- 尽管死亡率相似,接受r-tPA的患者在卒中后第一年居家时间更多、养老院入住更少,提示该治疗具有长期获益与安全性。
研究设计与样本
- 研究使用加拿大安大略卒中登记,识别2002至2013年诊断为缺血性卒中的患者及其基线特征与是否接受r-tPA。
- 采用倾向评分方法将接受r-tPA治疗的患者与未治疗患者进行匹配。
- 登记中全部4449例接受r-tPA治疗的患者均匹配到未治疗患者。
- 主要结局为1年居家时间,即入院索引日期后前365天内在任何医疗机构之外度过的天数。
- 次要结局为第一年养老院入住与全因死亡,结局由关联行政数据确定。
主要发现
- 溶栓组1年平均居家时间为248.9天±137.2天,未治疗组为239.4天±139.0天,P=0.005。
- 溶栓组养老院入住率为9.4%,未治疗组为12.2%,风险比0.84,95%CI 0.78-0.91。
- 两组1年全因死亡率相似:溶栓组13.2%,未治疗组12.4%,风险比1.07,95%CI 0.96-1.20。
临床怎么用
- 对符合指征的缺血性卒中患者,r-tPA治疗除早期功能获益外,还可能增加1年居家时间并减少养老院入住。
- 与患者和家属沟通长期预后时,可参考两组死亡率相似而居家时间与养老院入住存在差异的结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Intravenous thrombolysis with r-tPA (recombinant tissue-type plasminogen activator) is associated with improved early functional outcome after stroke, but its long-term effects are less understood. We aimed to determine the association between r-tPA and 1-year outcomes after stroke. Methods- We used the Ontario Stroke Registry to identify patients diagnosed with ischemic stroke between 2002 and 2013 in Ontario, Canada, their baseline characteristics, and whether they received r-tPA. We used propensity score methods to match patients treated with r-tPA to nontreated patients. The primary outcome was 1-year home-time, defined as the number of days spent outside of any healthcare institutions in the first 365 days after the index date of admission. Secondary outcomes were admission to a nursing home and all-cause mortality in the first year. Outcomes were determined using linked administrative data. We used paired t tests to compare mean home-time days and Cox proportional hazards models for mortality and nursing home admission to estimate hazard ratios and 95% CI. Results- All 4449 patients treated with r-tPA in the registry were matched to nontreated patients. Compared with nontreated patients, those treated with r-tPA experienced more time at home in the first year (mean±SD was 248.9 days±137.2 treated versus 239.4 days±139.0 nontreated, P=0.005) and were less likely to be admitted to nursing homes (9.4% treated versus 12.2% nontreated; hazard ratio, 0.84; 95% CI, 0.78-0.91). One-year all-cause mortality was similar between the 2 groups (13.2% treated versus 12.4% nontreated; hazard ratio, 1.07; 95% CI, 0.96-1.20). Conclusions- Despite similar mortality, patients who received r-tPA spent more time at home and were less likely to require nursing home admission in the first year after stroke compared with nontreated patients, suggesting long-term benefits and safety of this treatment.
引用
- Yu AYX, Fang J, Kapral MK, et al. One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis. Stroke. 2019. PMID: 31570086. doi:10.1161/STROKEAHA.119.026922
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。